The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer

PURPOSE: Low expression of HER2 (HER2-low expression) in breast cancer (BC) has unique biological characteristics. However, whether HER2-low expression has an impact on neoadjuvant chemotherapy (NACT) in HER2-negative breast cancer remains unclear. METHODS: This study reviewed the clinicopathologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Zhu, Tingting, Chen, Hao, Yao, Yongzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202994/
https://www.ncbi.nlm.nih.gov/pubmed/36586066
http://dx.doi.org/10.1007/s12094-022-03062-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202994/
https://www.ncbi.nlm.nih.gov/pubmed/36586066
http://dx.doi.org/10.1007/s12094-022-03062-9

Ejemplares similares